Treatment of corneal ulcers by local ultraviolet crosslinking (an experimental study)
https://doi.org/10.21516/2072-0076-2020-13-4-48-57
Abstract
About the Authors
V. V. NeroevRussian Federation
Vladimir V. Neroev — Academician of RAS, Dr. of Med. Sci., professor, director
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
E. V. Yani
Russian Federation
Elena V. Yani — Cand. of Med. Sci., department of infectious and allergic eye diseases, head
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
E. N. Iomdina
Russian Federation
Elena N. Iomdina — Dr. of Biol. Sci., professor principal researcher department of refraction pathology, binocular vision and ophthalmoergonomics
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
I. P. Khoroshilova-Maslova
Russian Federation
Inna P. Khoroshilova-Maslova — Dr. of Med. Sci., professor, department of the eye pathologic anatomy and histology, head
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
V. A. Golikova
Russian Federation
Viktorija A. Golikova — PhD student, department of infectious and allergic eye diseases
14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062
A. V. Kiryukhin
Russian Federation
Anton V. Kiryukhin — engineer
building B, 48, Vysokovoltnaya St., Ryazan, 390029
References
1. Oladigbolu K., Rafindadi A., Abah E., Samaila E. Corneal ulcers in a tertiary hospital in Northern Nigeria. Ann Afr Med. 2013 Jul-Sep; 12 (3): 165–70. doi: 10.4103/1596-3519.117626
2. Al Mahmoud T., Elhanan M., Elshamsy M.H., Alshamsi H.N., Abu-Zidan F.M. Management of infective corneal ulcers in a high-income developing country. Medicine (Baltimore). 2019 Dec; 98 (51):е18243. doi: 10.1097/MD.0000000000018243
3. Alio J.L., Abbouda A., Valle D., et al. Corneal crosslinking and infectious keratitis: a systematic review with a meta-analysis of reported cases. J. Ophthalmic Inflamm. Infect. 2013; 3: 47. doi: 10.1186/1869-5760-3-47
4. Neroev V.V., Petukhova A.B., Danilova D.Yu., Seliverstova K.E., Gundorova R.A. The cross-linking of corneal collagen in treatment of trophic and bacterial ulcers of cornea. Russian medical journal. 2013; 2: 25–8 (in Russian).
5. Wollensak G., Sporl E., Seiler T. Treatment of keratoconus by collagen cross linking. J. Ophthalmology. 2003; 100 (1): 44–9. doi: 10.1007/s00347-002-0700-3
6. Gomes J.A., Rapuano C.J., Belin M.W., Ambrosio R.Jr. Global consensus on keratoconus and ectatic diseases. Cornea. 2015; 34 (4): 359–69. doi: 10.1097/ICO.0000000000000408
7. Hafezi F., Kanellopoulos J., Wiltfang R., Seiler T. Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J. Cataract. Refract. Surg. 2007; 33 (12): 2035–40. PMID: 18053900
8. Kozobolis V., Labiris G., Gkika M. UV-A collagen cross-linking treatment of bullous keratopathy combined with corneal ulcer. Cornea, 2010; 29 (2): 235–8. doi: 10.1097/ICO.0b013e3181a81802
9. Pot S.A., Gallhöfer N.S., Matheis F.L., et al. Corneal collagen cross-linking as treatment for infectious and noninfectious corneal melting in cats and dogs: results of a prospective, nonrandomized, controlled trial. Vet. Ophthalmol. 2014; 17: 250–60. doi: 10.1111/vop.12090
10. Tabibian D., Richoz O., Riat A., Schrenzel J., Hafezi F. Accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis. J. Refract. Surg. 2014; 30 (12): 855–7. doi: 10.3928/1081597X-20141113-06
11. Makdoumi K., Mortensen J.C. Infectious keratitis treated with corneal crosslinking. Cornea, 2010; 29 (12): 1353–8. doi: 10.1097/ICO.0b013e3181d2de91
12. Bikbov M.M., Khalimov A.R., Usubov E.L. Ultraviolet corneal crosslinking. Annals of the Russian academy of medical sciences. 2016; 71 (3): 224–32 (In Russian). doi: 10.15690/vramn562
13. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr. Opin. Ophthalmol. 2006; 17: 356–60. doi: 10.1097/01.icu.0000233954.86723.25
14. Iomdina E.N. The biomechanical aspects of keratorefractive surgery and corneal cross-linking. Russian pediatric ophthalmology. 2015; 4: 32–7 (in Russian).
15. Spoerl E., Wollensak G., Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr. Eye Res. 2004; 29: 35–40.
16. Wollensak G., Iomdina E. Long-term biomechanical properties of rabbit cornea after photodynamic collagen crosslinking. Acta Ophthalmologica Scandinavica. 2009: 87 (1): 48–51. doi: 10.1111/j.1755-3768.2008.01190.x
17. Makdoumi K., Mortensen J., Sorkhabi O., Malmvall B.E., Crafoord S. UVARiboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefs Arch. Clin. Exp. Ophthalmol. 2012; 250: 95–102. doi: 10.1007/s00417-0111754-1
18. Makdoumi K., Bäckman A., Mortensen J., Crafoord S. Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefes Arch. Clin. Exp. Ophthalmol. 2010; 248: 207–12. doi: 10.1007/s00417-009-1231-2
19. Makdoumi K., Bäckman A. Photodynamic UVA-riboflavin bacterial elimination in antibiotic resistant bacteria. Clin. Exp. Ophthalmol. 2016; 44 (7 Sep.): 582–6. doi: 10.1111/ceo.12723
20. Martins S.A., Combs J.C., Noguera G., et al. Antimicrobial efficacy of riboflavin/ UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest. Ophthalmol. Vis. Sci. 2008; 49: 3402–8. doi: 10.1167/iovs.07-1592
21. Schrier A., Greebel G., Attla H., et al. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J. Refract. Surg. 2009; 25: S799–S802. doi: 10.3928/1081597X-20090813-07
22. Lamy R., Chan E., Good S.D., et al. Riboflavin and ultraviolet-A as adjuvant treatment against Acanthamoeba cysts. Clin. Experiment. Ophthalmol. 2015. doi: 10.1111/ceo.12644
23. Del Buey M.A., Cristóbal J.A., Casas P., et al. Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am. J. Ophthalmol. 2012; 153: 399–404. doi: 10.1016/j.ajo.2011.07.025
24. Letsch J., Abou-Bacar A., Candolfi E. Evaluation of in vitro efficacy of combined riboflavin and ultraviolet-A (365 nm) for Acanthamoeba. J. Fr. Ophthalmol 2015; 38: 213–9. 10.1016/j.jfo.2014.09.013
25. Makdoumi K., Backman A., Mortensen J., et al. Comparison of UVA- and UVA/ riboflavin-induced growth inhibition of Acanthamoeba castellani. Graefes Arch. Clin. Exp. Ophthalmol. 2013 Feb; 251 (2): 509–14. doi: 10.1007/s00417-0122176-4
26. Kashiwabuchi R.T., Carvalho F.R.S., Khan Y.A., et al. Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Invest. Ophthalmol. Vis. Sci. 2011; 52: 9333–8. doi: 10.1167/iovs.11-8382
27. Richotz O., Gatzioufas Z., Hafezi F. Corneal collagen cross-linking for the treatment of acanthamoeba keratitis. Cornea. 2013; 32 (10): 189. doi: 10.1097/ICO.0b013e31829a689e
28. Lim L., Lim E.W. A review of corneal collagen cross-linking — current trends in practice applications. Open Ophthalmol. J. 2018 Jul 23; 12: 181–213. doi: 10.2174/1874364101812010181
29. Bertollo C.M., Oliveira A.C., Rocha L.T. Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models. Eur. J. Pharmacol. 2006; 547: 184–91.
30. Price M.O., Tenkman L.R., Schrier A., et al. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J. Refract. Surg. 2012; 28 (10): 706–13. doi:10.3928/1081597x-20120921-06
31. Richoz O., Kling S., Hoogewoud F., et al. Antibacterial efficacy of accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL). J. Refract. Surg. 2014; 30: 850–4. doi: 10.3928/1081597X20141118-01
32. Hafezi F., Randleman J.B. PACK-CXL: defining CXL for infectious keratitis. J. Refract. Surg. 2014; 30: 438–9. doi: 10.3928/1081597X-20140609-01
33. Knyazer B., Krakauer Y., Baumfeld Y., et al. Accelerated PACK-CXL for moderate therapy-resistant infectious keratitis. Cornea. 2018; 37: 528–31. doi: 10.1097/ICO.0000000000001498
34. Makdoumi K., Mortensen J., Sorkhabi O., Malmvall B.E., Crafoord S. UVAriboflavin photochemical therapy of bacterial keratitis: A pilot study. Graefes Arch. Clin. Exp. Ophthalmol. 2012; 250 (1): 95–102. http://dx.doi.org/10.1007/s00417-011-1754-1 PMID: 21874347
35. Said D.G., Elalfy M.S., Gatzioufas Z., et al. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology. 2014; 121 (7): 1377–82. http://dx.doi.org/10.1016/j.ophtha.2014.01.011
36. Vajpayee R.B., Shafi S.N., Maharana P.K., Sharma N., Jhanji V. Evaluation of corneal collagen cross-linking as an additional therapy in mycotic keratitis. Clin. Experiment. Ophthalmol. 2015; 43 (2): 103–7. http://dx.doi.org/10.1111/ceo.12399
37. Uddaraju M., Mascarenhas J., Das M.R., et al. Corneal сrosslinking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: A randomized trial. Am. J. Ophthalmol. 2015; 160 (1): 131–4 e5. http://dx.doi.org/10.1016/j.ajo.2015.03.024
38. Torres-Netto E., Abrishamchi R., Shetty R., et al. Corneal cross-linking for the treatment of infectious keratitis: multicentre trial results. In: Abstracts of 24 th European Society of Cataract and Refractive Surgeons. Marrakech, Morocco. 2020. https://www.escrs.org/marrakech2020/Programme/freepapers-details.asp?id=35223&day=0
39. Papaioannou L., Miligkos M., Papathanassiou M. Corneal collagen cross-linking for infectious keratitis: a systematic review and meta-analysis. Cornea. 2016 Jan; 35 (1): 62–71. doi: 10.1097/ICO.0000000000000644
40. Chan T.C, Lau TW, Lee J.W., et al. Corneal collagen cross-linking for infectious keratitis: an update of clinical studies. Acta Ophthalmol. 2015 Dec; 93 (8): 689–96. doi: 10.1111/aos.1275
41. Iomdina E.N., Sotnikova L.F., Goncharova A.V., et al. Using ultraviolet corneal crosslinking for the treatment of corneal ulcers and other corneal pathologies in animals. Russian ophthalmological journal. 2019; 12 (3): 51–7 (In Russian). https://doi.org/10.21516/2072-0076-2019-12-3-51-57
42. Chentsova E.V., Verigo E.N., Makarov P.V., Khazamova A.I. Crosslinking in the complex treatment of corneal ulceration and corneal grafting. Russian ophthalmological journal. 2017; 10 (3): 93–100 (In Russian). https://doi.org/10.21516/2072-0076-201710-3-93-100
43. Kasparova E.A., Byao I., Sobkova O.I. Мodified cross-linking in the trеatment of advanced purulent corneal ulcer. Сlinical case. Ophthalmology in Russia. 2017; 14 (3): 274–7 (In Russian). https://doi.org/10.18008/1816-5095-20173-274-277
44. Tal K., Gal-Or O., Pillar S., et al. Efficacy of primary collagen cross-linking with photoactivated chromophore (PACK-CXL) for the treatment of Staphylococcus aureus-induced corneal ulcers. Cornea. 2015; 34: 1281–6. doi: 10.1097/ICO.0000000000000550
45. Cosar C.B., Kucuk M., Celik E., et al. Microbiologic, pharmacokinetic, and clinical effects of corneal collagen cross-linking on experimentally induced Pseudomonas keratitis in rabbits. Cornea. 2015 Oct; 34 (10): 1276–80. doi: 10.1097/ICO.0000000000000516
46. Zhu Z., Zhang H., Yue J., et al. Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis. BMC Ophthalmol. 2018 Mar 2; 18 (1): 65. doi: 10.1186/s12886-0180727-0
47. Galperin G., Berra M., Tau J., et al. Treatment of fungal keratitis from Fusarium infection by corneal cross-linking. Cornea. 2012 Feb; 31 (2): 176–80. doi: 10.1097/ICO.0b013e318221cec7
48. Berra M., Galperín G., Boscaro G., et al. Treatment of Acanthamoeba keratitis by corneal cross-linking. Cornea. 2013 Feb; 32 (2): 174–8. doi: 10.1097/ICO.0b013e31825cea99
49. Shufang Wei, Cuiying Zhang, Shaoru Zhang, Yanyun Xu, Guoying Mu. Treatment results of corneal collagen cross-linking combined with riboflavin and 440 Nm blue light for bacterial corneal ulcer in rabbits. Current Eye Research. 2017; 42 (10): 1401–6. doi:10.1080/02713683.2017.1332767
50. Kasparov A.A., Kasparova E.A., Sobkova O.I., Young Biao, Oganesyan A.S. Method for treatment of the purulent corneal ulcers. Patent RU 2635454 (in Russian).
51. Bikbov M.M., Nikitin N.A., Surkova V.K., Zaynullina N.B. Method of modeling bacterial keratitis. Patent RU, N 2480845 (in Russian).
52. Schmack I., Müller M., Kohnen T. Microbial keratitis: understand, recognize, and treat — Part 1: general aspects and characteristics of bacterial keratitis. Klin. Monbl. Augenheilkd. 2018; 235 (3): 331–50. doi: 10.1055/s-0044-101286
53. Lietman A.A., Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017 Nov; 124 (11): 1678–89. doi: 10.1016/j.ophtha.2017.05.012
54. Neroev V.V., Yani E.V., Golikova V.A., Pozdnyakova V.V. Experimental evaluation of bacterial corneal ulcer treatment plans using glucocorticosteroid. Russian ophthalmological journal. 2020; 13 (2): 71–7 (In Russian). https://doi.org/10.21516/2072-0076-202013-2-71-77
Review
For citations:
Neroev V.V., Yani E.V., Iomdina E.N., Khoroshilova-Maslova I.P., Golikova V.A., Kiryukhin A.V. Treatment of corneal ulcers by local ultraviolet crosslinking (an experimental study). Russian Ophthalmological Journal. 2020;13(4):48-57. (In Russ.) https://doi.org/10.21516/2072-0076-2020-13-4-48-57